Literature DB >> 22115162

Endocrine disorders & female infertility.

David Unuane1, Herman Tournaye, Brigitte Velkeniers, Kris Poppe.   

Abstract

Female infertility occurs in about 37% of all infertile couples and ovulatory disorders account for more than half of these. The ovaries are in continuous interaction with the other endocrine organs. The interplay may account for infertility occurring at different levels and may render the diagnosis of infertility a difficult exercise for the involved physician. A hypothalamic cause of female infertility should be considered in an appropriate clinical context, with tests pointing to a hypogonadotropic hypogonadism. It can be functional, physiological or related to organic causes. Hyperprolactinemia has well characterized effects on the normal gonadal function and treatment is well established. Acromegaly and Cushing's disease may impair fertility at different levels, mechanisms involved however remain ill defined. Thyroid disorders, both hyperthyroidism and hypothyroidism, can interact with the ovaries, through a direct effect on ovarian function, but autoimmunity may be involved, as well as alterations of the sex hormone binding protein levels. Primary ovarian disorders, such as the polycystic ovary syndrome and primary ovarian insufficiency are frequent diseases, for which novel treatments are currently being developed and discussed. We will propose an algorithm for the diagnosis and approach of the female patient presenting with infertility on the basis of the available evidence in literature.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22115162     DOI: 10.1016/j.beem.2011.08.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  29 in total

1.  Female infertility: do we forget the thyroid?

Authors:  D Unuane; K Poppe
Journal:  J Endocrinol Invest       Date:  2015-04-07       Impact factor: 4.256

Review 2.  Prolactinoma through the female life cycle.

Authors:  Deirdre Cocks Eschler; Pedram Javanmard; Katherine Cox; Eliza B Geer
Journal:  Endocrine       Date:  2017-11-24       Impact factor: 3.633

3.  Structure of human cortisol-producing cytochrome P450 11B1 bound to the breast cancer drug fadrozole provides insights for drug design.

Authors:  Simone Brixius-Anderko; Emily E Scott
Journal:  J Biol Chem       Date:  2018-11-13       Impact factor: 5.157

Review 4.  Effect of Exercise on Ovulation: A Systematic Review.

Authors:  Osnat Hakimi; Luiz-Claudio Cameron
Journal:  Sports Med       Date:  2017-08       Impact factor: 11.136

Review 5.  Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure.

Authors:  Oldouz Shareghi-Oskoue; Leili Aghebati-Maleki; Mehdi Yousefi
Journal:  Stem Cell Res Ther       Date:  2021-08-11       Impact factor: 8.079

6.  The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis.

Authors:  Danfeng Du; Xuelian Li
Journal:  Int J Clin Exp Med       Date:  2013-10-25

Review 7.  Endocrine autoimmune diseases and female infertility.

Authors:  Aritro Sen; Vitaly A Kushnir; David H Barad; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2013-11-05       Impact factor: 43.330

8.  Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study of 232 patients.

Authors:  Marta Araujo-Castro; Eider Pascual-Corrales; Alberto Acitores Cancela; Sara García Duque; Luis Ley Urzaiz; Víctor Rodríguez Berrocal
Journal:  Endocrine       Date:  2020-08-12       Impact factor: 3.633

9.  Ovulation, a sign of health.

Authors:  Pilar Vigil; Carolina Lyon; Betsi Flores; Hernán Rioseco; Felipe Serrano
Journal:  Linacre Q       Date:  2017-11-27

10.  Effect of cognitive behavioral therapy-based counseling on perceived stress in pregnant women with history of primary infertility: a controlled randomized clinical trial.

Authors:  Farideh Golshani; Shirin Hasanpour; Mojgan Mirghafourvand; Khalil Esmaeilpour
Journal:  BMC Psychiatry       Date:  2021-05-31       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.